Expert Ratings for Pliant Therapeutics
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Pliant Therapeutics (NASDAQ:PLRX) in the last quarter. In the last 3 months, 9 analysts have offered 12-month price targets for Pliant Therapeutics with an average price target of $51.56, a decrease of 0.21% from the previous average price target of $51.67.
September 15, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pliant Therapeutics has received bullish ratings from analysts, with an average price target of $51.56.
The bullish ratings from analysts indicate a positive outlook for Pliant Therapeutics. The average price target of $51.56, although slightly lower than the previous target, still suggests potential upside for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100